NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
1.290
-0.010 (-0.77%)
Nov 21, 2024, 3:32 PM EST - Market open
NextCure Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
82
Market Cap
36.09M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
DIH Holding US | 72.41M |
Carisma Therapeutics | 20.27M |
Barinthus Biotherapeutics | 14.97M |
Dyadic International | 3.36M |
Beyond Air | 2.34M |
Lumos Pharma | 2.21M |
Eterna Therapeutics | 598.00K |
Lexaria Bioscience | 411.02K |
NXTC News
- 2 days ago - Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta - GlobeNewsWire
- 13 days ago - NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 15 days ago - NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual Meeting - GlobeNewsWire
- 6 weeks ago - NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting - GlobeNewsWire
- 2 months ago - NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024 - GlobeNewsWire
- 5 months ago - NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - GlobeNewsWire
- 6 months ago - NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024 - GlobeNewsWire
- 7 months ago - NextCure Provides Business Update and Reports First Quarter 2024 Financial Results - GlobeNewsWire